🧫
experiment

Human iPSC-derived AD model with optical electrophysiology demonstrated that mTOR inhibition ameliorates spheroid pathology, revealing reversible mechanisms of axonal pathology.

🧫 Experiment Protocol Cell BiologyAlzheimer's diseaseMTORipscextracted
iPSC-derived neurons with optical electrophysiology for functional studies
PRIMARY OUTCOME
Human iPSC-derived AD model with optical electrophysiology demonstrated that mTOR inhibition ameliorates spheroid pathology, revealing reversible mechanisms of axonal pathology.
LINKED HYPOTHESES
Source: pmid_40065072
🧫 Experiment Extras
PATHWAY
PI3K/AKT/mTOR
MARKET PRICE
$0.50
STATUS
extracted
Related Target
MTORcomposite 0.419
View on SciDEX ↗